Capturing Value in a Fast-Paced, Disruptive Industry

Emily Event News Leave a Comment

Nextech Invest Ltd. runs the world’s first late stage oncology fund. Founded in 1998, this investment firm raised more than USD 300 million and currently manages USD 220 million on oncology. Representing Nextech Invest is its founder & partner, Mr Alfred Scheidegger who will be giving a keynote presentation on How to Capture Value in a Fast-Paced, Disruptive Industry” at Phar-East 2018, Singapore. …

Educated Guesses, Lofty Aspirations & Hard Realities: CellResearch Corp’s Ivor Lim on succeeding as a biotech in Asia

Emily Event News Leave a Comment

The transition from bench research to bedside application seems very straightforward at first glance, but it is not until the first steps are taken that one realises the numerous hurdles that must be overcome in order to achieve this. At Phar-East 2018, we bring successful bio entrepreneurs, pharma executives, top investors and more together from across Asia to share their …

Meeting Amwise – a Singapore biotech start up on cancer precision medicine and medical AI

Emily Event News Leave a Comment

In this write up, we feature Sean Huang, Founder of Amwise. This biotech start up is a leading brand in precision medicine to serve the well being of Asia cancer patients. The patented examination technology of Amwise is developed based on Asian genes and can identify the risk of tumor recurrence or metastasis, assisting doctors with second opinions. Amwise aims to …

Case study: Areteon, Singaporean company working to solve the global AMR problem

Emily Event News Leave a Comment

Drug-resistant microbial is one of the hottest topics of the 21st century. With the potential to cause nearly $100 trillion in damage to the world’s health and economy, the issue of infections untreatable by modern antibiotics is one that leaves many concerned and looking for solutions. But did you know a Singapore-based biotech company is part of effort to prevent …

Expanding from a pure API provider to new drug developer: Formosa is growing

Emily Event News Leave a Comment

Pictured Erick Co, CSO of Formosa Pharmaceutical during the acquisition of Activus Pharma, August 2017.  Formosa Pharma, Taiwan is a subsidiary of globally-recognized API provider, Formosa Laboratories. This preclinical and clinical stage biopharmaceutical company has a strong focus on anti-infective and oncology indications. Having recently acquired Activus Pharma and its Activus Pure Nanoparticle Technology Platform (APNT), Formosa Pharmaceuticals is growing …

10 minutes with Marc Voigt, CEO of Immutep (Previously known as Prima Biomed)

Emily Event News 1 Comment

Prima Biomed was originally built on CVac, a therapeutic cancer vaccine. With its recent shift to embrace multiple products, the company has decided to rebrand itself to Immutep, named after a subsidy acquired in 2014. Leading the company is Marc Voigt, who will join us at Phar-East 2018 to speak about their vision of the next big immune checkpoint in the immunotherapy race. …

top 8 immunotherapy companies

CStone, OBI, Tessa Therapeutics & more join other immunotherapy leaders at Phar-East 2018

Emily Event News Leave a Comment

In case you missed our email last week, we shared 8 fantastic immunotherapy experts confirmed to speak at Phar-East 2018, Singapore, taking place 28th February to 2nd March. Speaking on their latest work, these distinguished speakers from Asia pharma industry will share their experience, lessons learnt and future plans. First of all, we have Frank Jiang, CEO and founder of CStone. Recently …

Biotech Highlight: Pacific Gene Tech (PGT)

Emily Event News Leave a Comment

Pacific Gene Tech (PGT) is an Asian vaccine company developing and commercialising first and/or best-in-class vaccines for areas of high unmet or under-served needs in food safety and livestock animal health. While working on livestock diseases, they discovered that one of their proprietary platforms has broad cross-protection for both human and livestock industries. Led by an experienced management team and advised …

Cyca Oncosolutions- An India oncology drug delivery biotech company

Emily Event News Leave a Comment

Bioentrepreneurship is not an easy path to take, especially in developing countries such as India with limited public financial support. Best described as a scientist, entrepreneur and motivator, Nusrat Jahan Sanghamitra, founder of Cyca OncoSolutions is committed to make a difference in people’s lives by her scientific and personal endeavors. Starting as a researcher with a mission ‘to find a better anticancer …

Highlight: OCT Therapies, an early stage stem cell therapy biotech in India

Emily Event News 2 Comments

You probably already know that we have a line up of near 20 early stage biotech speakers joining us at the 15th Biopharma India happening in Grand Hyatt Mumbai this 19-20 September. In this week’s update, we feature OCT Therapies, an exciting company working on stem cell therapies, to give you a preview before their presentation at the conference. Caroline Mathen, CEO and …